Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 5—May 2002

Dispatch

Increasing Quinolone Resistance in Salmonella enterica serotype Enteritidis

Kåre Mølbak*, Peter Gerner-Smidt*, and Henrik C. Wegener†
Author affiliations: *Statens Serum Institut, Copenhagen, Denmark; †Danish Zoonosis Centre, Copenhagen, Denmark;

Main Article

Table

Prevalence of quinolone resistance in human isolates of Salmonella enterica serotype Enteritidis, by phage type and history of foreign travel. Denmark, 1995–2000.

Phage type No history of foreign travel Foreign travel
No. resistant (%) Total No. resistant (%) Total
1 22 (23.4) 94 11 (29.7) 37
4 7 (2.4) 292 5 (3.8) 131
6 4 (0.5) 765 0 (-) 28
6A 1 (5.9) 17 4 (22.2) 18
8 8 (1.3) 627 0 31
13A 0 (-) 9 0 4
14B 1 (20.0) 5 1 (14.3) 7
21 3 (4.9) 61 0 4
21B 0 (-) 16 0 0
25 0 (-) 19 0 0
34 0 (-) 81 0 2
Others and nontypeable 6 (3.9) 152 4 (13.8) 29
Not typed 2 (1.9) 105 2 (18.2) 11
Total 54 (2.4) 2,243 27 (8.9) 302

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO